Board of directors

José Achache
Chairman

José is a dual-national French / Swiss expert in deep technology development and commercialisation with a combined academic, institutional and industrial experience.
José graduated from the Ecole Normale Supérieure in Paris with PhDs in Physics and Geophysics and subsequently completed a postdoc at Stanford University. He has served as a Professor at the Institut de Physique du Globe de Paris, one of the campuses of the Université Paris Cité.
While publishing numerous scientific papers, José also published, in 2005, a book essay on the economics of space for environment and security: Les Sentinelles de la Terre.
With an industrial and product development perspective, José has served as Executive Director of several French and international R&D agencies including BRGM, CNES and the European Space Agency. He is currently serving as the Chairman and Director of several deep technology companies in Switzerland, Italy and France and is an entrepreneur at heart.

Jean Van Den Esch

Jean joined the company early after its inception in 2013 as Chairman of the Board of Directors. Jean is in charge of legal affairs, management of company governance bodies, capital increases, adaptations of the legal framework of the company to the rapid growth of its activity. From 2000, he created a family office and manages the patrimonial interests of several French families. From 1995 to 2000, he was managing director of Marechal SA, a manufacturer of industrial electrical connectors. Initially, he was tax lawyer and former associate director at FIDAL cabinet. Jean obtained a Master Degree in Business Law from Paris I University (Pantheon) and is graduated from IAE of Paris Dauphine University.

Jean Michel Levy

He was Senior VP "Mergers and Acquisitions and Business Development" in Sanofi and member of the Executive Committee. He participated to the genesis of ILTOO Pharma regarding business matters. Throughout his career in the pharmaceutical industry, he was dedicated to licensing and Merger & Acquisitions activities being an enabler for Sanofi’s growth in the last 20 years. Jean-Michel brings ILTOO Pharma its overall strategic vision and its extensive experience in business development and negotiations.
Jean Michel holds a Master Degree in business administration from Paris HEC Business School.

Pierre Belichard

Pierre is a co-founder and Chief Executive Officer of Enterome. He has been a member of the founding teams of several biotech companies. Before creating Enterome in 2012, Pierre was VP M&A and business development at Sanofi Ophthalmology. Being the founder and COO of Fovea Pharmaceuticals, he has been instrumental in building up the product-portfolio that became the Ophthalmology division of Sanofi (Fovea was acquired by sanofi in 2009, less than five years after inception).
Earlier, Pierre was VP Business Development at UroGene, a company sold to Pierre Fabre in 2004. In 2000, he took over the position of head of European commercial operations at Ethypharm. Prior to this, Pierre held various positions in science and business development at Fournier Pharma. Pierre is PharmD, PhD and holds a MBA from INSEAD.

Antoine Barouky

Antoine Barouky is a dedicated professional with a proven track record of successfully delivering on challenging projects that have previously failed. Antoine worked for 12 years to transform and grow leading company from €40M to €235M through sales by mainly launching a new product across all EU countries including opening new subsidiaries including US & out-licensing deals. He led the change of control - acquisition by private equity - of the company followed by 2 M&A in the US. He has also successfully started from scratch French, Italian, Spanish & Benelux operations for three US companies for hospital & retail products in rare/orphan & critical care diseases. Antoine has also led a successful turnaround of the rare diseases business unit of Shire France. Antoine joins ILTOO Pharma at a time when commercial development is of critical importance.